|
| |
BioReports
Biotechnology, Pharmaceutical and Life
Science Reports Listing (October 2007)
- CurrentPartnering
- Combined Bigpharma Dealmaking and Agreements Handbook 2007
- Bigpharma Agreements Handbook 2007
- Bigpharma Dealmaking Handbook 2007
- Life Science Analytics
- Women's Health Vaginal Infections Drug Pipeline Report
- Women's Health Menopausal Symptoms Drug Pipeline Report
- Women's Health Infertility Drug Pipeline Report
- Women's Health Female Sexual Dysfunction Drug Pipeline Report
- Women's Health Endometriosis Drug Pipeline Report
- Women's Health Contraception Drug Pipeline Report
- Substance Abuse Smoking Cessation Drug Pipeline Report
- Substance Abuse Poisoning Drug Pipeline Report
- Substance Abuse Antidote Drug Pipeline Report
- Substance Abuse Alcoholism Drug Pipeline Report
- Respiratory and Pulmonary System Nasal congestion Drug Pipeline Report
- Respiratory and Pulmonary System Cystic Fibrosis Drug Pipeline Report
- Respiratory and Pulmonary System Cough Drug Pipeline Report
- Respiratory and Pulmonary System Chronic Obstructive Pulmonary Disease Drug
Pipeline Report
- Respiratory and Pulmonary System Bronchospasm Drug Pipeline Report
- Respiratory and Pulmonary System Bronchitis Drug Pipeline Report
- Respiratory and Pulmonary System Asthma Drug Pipeline Report
- Ophthalmology and Optometry Ocular Inflammation Drug Pipeline Report
- Ophthalmology and Optometry Macular Degeneration Drug Pipeline Report
- Ophthalmology and Optometry Glaucoma Drug Pipeline Report
- Ophthalmology and Optometry Eye Infections Drug Pipeline Report
- Ophthalmology and Optometry Dry Eyes Drug Pipeline Report
- Ophthalmology and Optometry Conjunctivitis Drug Pipeline Report
- Musculo-Skeletal-Disorders Osteoarthritis Drug Pipeline Report
- Musculo-Skeletal-Disorders Muscle Pain Drug Pipeline Report
- Musculo-Skeletal-Disorders Gout Drug Pipeline Report
- Metabolic Endocrinology Vitamin Deficiency Drug Pipeline Report
- Metabolic Endocrinology Type II Diabetes Drug Pipeline Report
- Metabolic Endocrinology Type I Diabetes Drug Pipeline Report
- Metabolic Endocrinology Obesity Drug Pipeline Report
- Metabolic Endocrinology Hypogonadism Drug Pipeline Report
- Metabolic Endocrinology Hypocalcemia Drug Pipeline Report
- Metabolic Endocrinology Hypercalcemia Drug Pipeline Report
- Metabolic Endocrinology Diabetic Neuropathy Drug Pipeline Report
- Metabolic Endocrinology Cachexia Drug Pipeline Report
- Kidneys and Genito-Urinary System Urinary Incontinence Drug Pipeline Report
- Kidneys and Genito-Urinary System Overactive Bladder Drug Pipeline Report
- Kidneys and Genito-Urinary System Kidney Stones Drug Pipeline Report
- Kidneys and Genito-Urinary System Hyperphosphatemia Drug Pipeline Report
- Kidneys and Genito-Urinary System Erectile Dysfunction Drug Pipeline Report
- Kidneys and Genito-Urinary System Diabetic Nephropathy Drug Pipeline Report
- Kidneys and Genito-Urinary System Benign Prostatic Hyperplasia Drug Pipeline
Report
- Infections Viral Infections Drug Pipeline Report
- Infections Urinary Tract Infections Drug Pipeline Report
- Infections Tuberculosis Drug Pipeline Report
- Infections Staphylococcal Infections Drug Pipeline Report
- Infections Pneumonia Drug Pipeline Report
- Infections Malaria Drug Pipeline Report
- Infections Influenza Drug Pipeline Report
- Infections Herpes Simplex Virus Infection Drug Pipeline Report
- Infections Hepatitis C Drug Pipeline Report
- Infections Hepatitis B Drug Pipeline Report
- Infections Helminthic Infestations Drug Pipeline Report
- Infections Fungal Infections or Candidiasis Drug Pipeline Report
- Infections Fever Drug Pipeline Report
- Infections Ear Infections Drug Pipeline Report
- Infections Bacterial Infections Drug Pipeline Report
- Infections AIDS HIV Drug Pipeline Report
- Genetic Diseases and Dysmorphic Syndromes Turner's Syndrome Drug Pipeline
Report
- Genetic Diseases and Dysmorphic Syndromes Gaucher's Disease Drug Pipeline
Report
- Digestive System Ulcers Drug Pipeline Report
- Digestive System Ulcerative Colitis Drug Pipeline Report
- Digestive System Peptic Ulcer or Gastric Ulcer or Duodenal Ulcer Drug Pipeline
Report
- Digestive System Nausea and Vomiting Drug Pipeline Report
- Digestive System Irritable Bowel Syndrome Drug Pipeline Report
- Digestive System Indigestion Drug Pipeline Report
- Digestive System Gastroesophageal Reflux Disease Drug Pipeline Report
- Digestive System Diarrhea Drug Pipeline Report
- Digestive System Constipation Drug Pipeline Report
- Digestive System Acidity Drug Pipeline Report
- Dermatology Wounds or Wound Dressing Drug Pipeline Report
- Dermatology Skin Infections or Dermatosis or Skin Itching Drug Pipeline Report
- Dermatology Eczema Drug Pipeline Report
- Dermatology Burns Drug Pipeline Report
- Dermatology Alopecia (Hair Loss) Drug Pipeline Report
- Dermatology Acne Drug Pipeline Report
- Dental Gingivitis or Periodontitis Drug Pipeline Report
- Dental - Dental - Pain Drug Pipeline Report
- Dental Caries Drug Pipeline Report
- Central Nervous System Stroke Drug Pipeline Report
- Central Nervous System Seizures Drug Pipeline Report
- Central Nervous System Schizophrenia Drug Pipeline Report
- Central Nervous System Parkinson Disease Drug Pipeline Report
- Central Nervous System Pain Drug Pipeline Report
- Central Nervous System Multiple Sclerosis Drug Pipeline Report
- Central Nervous System Neuropathy Drug Pipeline Report
- Central Nervous System Migraine Drug Pipeline Report
- Central Nervous System Insomnia or Sleep Disorders Drug Pipeline Report
- Central Nervous System Headache Drug Pipeline Report
- Central Nervous System Epilepsy Drug Pipeline Report
- Central Nervous System Depression Drug Pipeline Report
- Central Nervous System Dementia Drug Pipeline Report
- Central Nervous System Anxiety Drug Pipeline Report
- Central Nervous System Alzheimer Disease Drug Pipeline Report
- Cardiovascular and Circulatory System Thrombosis Drug Pipeline Report
- Cardiovascular and Circulatory System Stroke Drug Pipeline Report
- Cardiovascular and Circulatory System Peripheral Vascular Disease Drug
Pipeline Report
- Cardiovascular and Circulatory System Myocardial Infarction Drug Pipeline
Report
- Cardiovascular and Circulatory System Ischemia Drug Pipeline Report
- Cardiovascular and Circulatory System Intermittent Claudication Drug Pipeline
Report
- Cardiovascular and Circulatory System Hypertension Drug Pipeline Report
- Cardiovascular and Circulatory System Hypercholesterolemia Drug Pipeline
Report
- Cardiovascular and Circulatory System Edema Drug Pipeline Report
- Cardiovascular and Circulatory System Congestive Heart Failure Drug Pipeline
Report
- Cardiovascular and Circulatory System Atherosclerosis or Coronary Artery
Disease Drug Pipeline Report
- Cardiovascular and Circulatory System Arrhythmiasis Drug Pipeline Report
- Cardiovascular and Circulatory System Angina Drug Pipeline Report
- Prostate Cancer Drug Pipeline Report
- Pancreatic Cancer Drug Pipeline Report
- Ovarian Cancer Drug Pipeline Report
- Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Drug
Pipeline Report
- Non-Hodgkin Lymphoma Drug Pipeline Report
- Multiple Myeloma Drug Pipeline Report
- Melanoma or Skin Cancer Drug Pipeline Report
- Liver Cancer Drug Pipeline Report
- Kidney Cancer Drug Pipeline Report
- Head and Neck Cancer Drug Pipeline Report
- Gastrointestinal Stomach Cancer Drug Pipeline Report
- Breast Cancer Drug Pipeline Report
- Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or
Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell
Leukemia Drug Pipeline Report
- Blood and Lymphatic System Thromboembolism Drug Pipeline Report
- Blood and Lymphatic System Myelodysplastic Syndrome Drug Pipeline Report
- Blood and Lymphatic System Hyperlipemia Drug Pipeline Report
- Blood and Lymphatic System Hemophilia or Blood Coagulation Disorders Drug
Pipeline Report
- Blood and Lymphatic System Electrolyte Deficiencies Drug Pipeline Report
- Blood and Lymphatic System Dyslipidemia Drug Pipeline Report
- Blood and Lymphatic System Anemia Drug Pipeline Report
- Autoimmune and Inflammation Transplant Rejection or Transplantation Drug
Pipeline Report
- Autoimmune and Inflammation Rheumatoid Arthritis Drug Pipeline Report
- Autoimmune and Inflammation Lupus Drug Pipeline Report
- Autoimmune and Inflammation Inflammation Drug Pipeline Report
- Autoimmune and Inflammation Crohn Disease Drug Pipeline Report
- Autoimmune and Inflammation Autoimmune Diseases Drug Pipeline Report
- Autoimmune and Inflammation Arthritis Drug Pipeline Report
- Autoimmune and Inflammation Allergy Drug Pipeline Report
- Insight Pharma Reports
- Adaptive Clinical Trials Innovations in Trial Design Management and Analysis
- Next-Generation Sequencing Scientific and Commercial Implications of the $1000
Genome
- Clinical Forecasting A Novel Bayesian Tool for Predicting Phase III Outcomes
- Best Practices
- Delivering Maximum Brand Impact Via Pharmaceutical Market Analytics
- Building and Sustaining Impactful Competitive Intelligence Organizations
- Pharmaceutical Sales Training: Turning New Hires into Top Performers
- Cross-Industry Field Sales Force Excellence
- Hiring Top Talent: Best Practices in University Recruiting
- HR Resourcing Excellence Series
- Managing Cross-Functional Teams for Pharmaceutical Product Commercialization
Excellence
- Integrating Quality into Business Systems for High Performance
- Pharma Sales Force Effectiveness: Increasing Productivity Through Streamlined
Internal Communication
- Scientific Publications Strategy: Managing Reputation, Clinical Trial Results
and Commercial Relevance
- VennBio Ltd
- Peripheral Neuropathy and Neuropathic Pain, 2007
- Antibiotics and Drug Resistance 2007
- Cancer Stem Cells Emerging Therapeutic Diagnostic and Market Opportunities
- Mehta Partners
- Global Pharmaceutical and Biotechnology Outlook 2007
- Executive Summary and Macro Overview Positives and Negatives Facing The Sector
- Future Drivers Drug Launches
- Future Drivers Generics and Biosimilars
- Consolidation
- Therapeutic Class Overviews
- Global Pharma US and Europe
- Global and Emerging Japan
- Specialty Pharma US and Europe
- Mature Biotech US and Europe
- Rising Stars Unprofitable Biotech US and Europe
- Emerging Countries India
- Company Milestones
- Appendices and Index
- Class Overviews Alzheimer's Disease
- Class Overviews Diabetes
- Class Overviews Hepatitis C includes full Market Model
- Class Overviews High Density Lipoproteins
- Class Overviews HSP90 Antagonists
- Class Overviews Obesity
- Class Overviews Lupus
- PharmaVentures
- Pricing and Reimbursement Risk and Opportunity in Pharmaceutical Deal Making
- The Pharmaceutical Deals of 2006
- Valuing and Structuring Pharmaceutical Licensing Agreements
- Facts and Trends in Deal Making - A Perspective on the Pharma and Biotech
Industries
- Pharmaceutical Deal Structures - The Essential Manual for Deal Makers
- Nanotechnology-Based Drug Delivery Systems in Japan
- A Guide to Royalty Rates in Pharmaceutical Licensing Deals
- Strategies and Tactics for Successful Partnering
- Deal Making in the New Healthcare Landscape
- Effective Licensing and Commercialisation of Drug Delivery Systems 2006
- Spotlight on Influenza - Separating Fact from Fiction in the Battle Against
Influenza
- PharmaDeals® Deal Making Spotlight Reports
- Deal Making Spotlight on Novartis
- Deal Making Spotlight on Johnson and Johnson
- Deal Making Spotlight on GlaxoSmithKline
- Deal Making Spotlight on sanofi-aventis
- Deal Making Spotlight on Pfizer
- Biotech Learning Institute eLearning online courses
- Professional Designation in Breast Cancer- 3 Course Curriculum
- Breast Cancer - Etiology and Epidemiology (Course)
- Breast Cancer - Diagnosis (Course)
- Breast Cancer - Treatment and Prognosis (Course)
- Acid-related Disorders - Three Course Suite
- Acid-related Disorders - Cause (Course)
- Acid-related Disorders - Diagnosis (Course)
- Type 2 Diabetes - Three Course Suite
- Type 2 Diabetes - Cause (Course)
- Type 2 Diabetes - Diagnosis (Course)
- Type 2 Diabetes - Treatment (Course)
- Rhinitis - Three-Course Suite
- Rhinitis - Cause (Course)
- Rhinitis - Diagnosis (Course)
- Rhinitis - Treatment (Course)
- Rheumatoid Arthritis - Three Course Suite
- Rheumatoid Arthritis - Cause (Course)
- Rheumatoid Arthritis - Diagnosis (Course)
- Rheumatoid Arthritis - Treatment (Course)
- Overactive Bladder (OAB) - Three Course Suite
- Overactive Bladder (OAB) - Cause (Course)
- Overactive Bladder (OAB) - Diagnosis (Course)
- Overactive Bladder (OAB) - Treatment (Course)
- Neuropatic Pain - Three Course Suite
- Neuropathic Pain - Cause (Course)
- Neuropathic Pain - Diagnosis (Course)
- Neuropathic Pain - Treatment (Course)
- Non-small Cell Lung Cancer (NSCLC) - Three Course Suite
- Non-small Cell Lung Cancer - Cause (Course)
- Non-small Cell Lung Cancer - Diagnosis (Course)
- Non-small Cell Lung Cancer - Treatment (Course)
- Introduction to Oncology - Five Course Suite
- Introduction to Oncology - The Cell Cycle (Course)
- Introduction to Oncology - Apoptosis and Oncogenes (Course)
- Introduction to Oncology- Metastasis and Staging (Course)
- Introduction to Oncology - System Involvement (Course)
- Introduction to Oncology - Treatment (Course)
- Professional Designation in Schizophrenia - 3 Course Curriculum
- Schizophrenia - Cause (Course)
- Schizophrenia - Diagnosis (Course)
- Schizophrenia - Treatment (Course)
- Professional Designation in Anxiety Disorders - 3 Course Curriculum
- Anxiety Disorder - Treatment (Course)
- Anxiety Disorder - Diagnosis (Course)
- Anxiety Disorder - Cause
- Regulatory and Compliance (GxP) e-Learning Curriculum
- 21 CFR Part 11 course
- Biostatistics course
- Good Manufacturing Practice (GMP) Course
- Good Laboratory Practice (GLP) course
- Good Clinical Practice, Level II (GCP) course
- Good Clinical Practice I (GCP) course
- Professional Designation in Advanced Biotechnology and Bioinformatics - 5
Course Curriculum
- Microarray Informatics Course
- Methods in Molecular Biology Course
- Advanced Bioinformatics Course
- SNPs - Identification and Uses Course
- Microarrays Course
- Professional Designation in Biotechnology and Bioinformatics - 6 Course
Curriculum
- Introduction to Bioinformatics Course
- Immunity and Disease Course
- Computer-Assisted Drug Design Course
- Combinatorial Chemistry Course
- Genomics Course
- Human Gene Therapy Course
- Professional Designation in Biopharmaceuticals Technology - 3 Course
Curriculum
- Introduction to Biopharma - Applications Course
- Introduction to Biopharma - Methods Course
- Introduction to Biopharma - Basics Course
- Beachhead
- Beyond Expression Arrays Emerging Applications for Genomic Microarray
Technology
- Synthetic Biology: A New Paradigm for Biological Discovery
- BioInformatics 06
- Customer Satisfaction and Loyalty in the Life Sciences Boosting Profit Through
Exceptional Service and Support
- eCommerce Strategies for the Life Science Market
- Improving Sales Rep Performance Life Scientists' Perspectives
- China's Guidebook for Pharmaceutical Patent Protection
- China Pharmaceutical Guidebook Material and Clinical Trial Requirements of
Application and Approval for Imported Drug Registration A Guidebook of
Registration Application for Imported Biological Products
- China Pharmaceutical Guidebook Material and Clinical Trial Requirements of
Application and Approval for Imported Drug Registration A Guidebook of
Registration Application for Imported Chemical Drugs
- Latest Chinese Regulations for Imported Drug Registration A Comprehensive
Guidebook for Foreign Pharmaceutical Companies
- China Pharmaceutical Guidebook Material and Clinical Trial Requirements of
Application and Approval for Imported Drug Registration A Guidebook of
Registration Application for Imported Traditional Chinese Medicines and Natural
Medicines
- eMarketing to Life Scientists Amplifying Your Marketing Message
- Optimizing Synthetic RNAi - Perspectives from the Pharmaceutical and Biotech
Industry
- Marketing to Life Scientists 2006 - Capitalizing on Media Engagement
- Market Opportunities in Biodefense Research - Trends and Forecasts
- The Global Market for Synthetic Oligonucleotides
- Customer Loyalty and Satisfaction - Creating a Branded Customer Experience
- Influencing Brand Preferences in the Flow Cytometry Market
- The Market for Antibodies: Keys to Success for Commercial Suppliers, Volume II
- Maximizing Market Share Through Brand Differentiation
- The Market for DNA Molecular Weight Markers: Climbing the Ladder to the top
- Securing a Competitive Advantage in the Reverse Transcriptase Market
- The Market for Restriction Enzymes Cutting Out Your Competition
- Advertising to Life Scientists Maximizing Ad Effectiveness
- Marketing to Life Scientists Navigating Channels Through Segmentation
- The Taq Wars Competitive Intelligence on How to Survive
- Kalorama
- Healthcare Opportunities for Food Ingredient Manufacturers
- OEM Contract Manufacturing in Medical Devices Vol II - Electronics and
Advanced Systems
- Retail Clinics - The Emerging Market for Convenience and In-Store Healthcare
- Prescribing Pharmacists - A Decision Maker Emerges
- A Guide to Drug Pricing and Reimbursement
- Orthopedic Biomaterials The World Market 2nd Edition
- Wound Care 3rd Edition Vol III Surgical and Trauma Wounds
- Wound Care 3rd Edition Vol II Burns
- OEM Contract Manufacturing in Medical Devices Vol I Materials Processing
- Clinical Nutrition Products World Market 2nd Edition
- Global Hepatitis Strategies
- Virtual Reality Applications in Healthcare U.S. Market
- Anesthesia Drugs Worldwide Markets
- Wound Care Markets 3rd. Edition Vol. I Skin Ulcers
- The Diagnostic Equipment Service Conundrum How Much Is Too Much? How Little Is
Too Little?
- DNA Sequencing Equipment and Services Markets
- Multiple Sclerosis World Market Outlook to 2011
- Early Toxicology Markets and Approaches
- Global Tuberculosis Strategies
- RFID Opportunities in Healthcare in the U.S.
- Asian Medical Device Markets
- U.S. Market for Home Care Products 5th Edition
- Physician Office Laboratory (POL) Testing Markets Worldwide Status Quo and
Future Trends
- Medical Imaging Markets Volume V Molecular Imaging
- Anti-Infectives World Markets 2nd Edition Vol. I-III Complete Series
- Anti-Infectives World Market 2nd Edition Vol III Antivirals
- Monoclonal Antibodies Vaccines and Other Immunologic Cancer Treatments World
Market
- Drug Delivery Markets Vol IV Transdermal
- Anti-Infectives World Market 2nd Edition Vol I Antifungals
- Drug Delivery Series I-IV
- Refractive Vision Correction A Market Analysis
- Smoking Cessation and Addiction Treatments A World Market Analysis
- Diabetes and Diabetic Complications Major World Markets 3rd Edition
- Medical Imaging Markets Volume IV Contrast Agents
- Drug Delivery Markets Vol III Pulmonary Delivery Systems
- Molecular Diagnostics Major World Markets
- Cancer Therapeutics The Worldwide Market 2nd Edition
- Drug Delivery Markets Vol II Implantable Injectable
- US Market for EMR Technologies Electronic Medical Records
- Wireless Opportunities in Healthcare
- Lateral Flow Technology and the Future of Point of Care Diagnostics
- Molecular Diagnostics - Major World Markets
- Clinical Diagnostics in India - Market Sector Analyses and Participant
Directory
- The Worldwide Market for Dialysis Equipment Supplies and Services 2nd Edition
- Vaccines - The World Market
- The World Market for Psychotherapeutic Drugs
- Drug Delivery Markets Vol I - Oral Delivery
- The World Market for Pain Management Drugs and Devices, 2nd Edition
- Cell Culture - The World Market for Media, Sera, and Reagents
- Biomarkers - A Market Briefing
- Biophotonics - A Strategic Assessment of Photonics Technologies for Biomedical
Applications
- Worldwide Point of Care (POC) - Are Decentralized Clinical Diagnostics a Cost
Drain or Revenue Driver?
- Mass Spectrometry in Protein Biomarker Applications - Software, Services, and
Instrument Markets
- The Emerging Cancer Vaccine Market, 2nd Edition
- Obesity - The Worldwide Market for Pharmaceutical and Surgical Treatment
- Cardiac Markers
- Medical Imaging Markets, Volume III - Ultrasound
- The World Market for Prescription Orthopedic Drugs
- The World Market for Prescription Respiratory Drugs
- Psoriasis and Psoriatic Arthritis - A Strategic Analysis of the Market in the
United States
- Pharmaceutical Outsourcing Opportunities Post-Launch - Contract Manufacturing
and Contract Sales and Marketing, 2nd Edition
- Blood - The Worldwide Market for Blood Products, Blood Testing, Blood
Equipment, and Synthetic Blood Products
- Medical Imaging Markets Volume II Magnetic Resonance
- Women's Health: Worldwide Prescription Drug Markets
- The World Market for Prescription Gastrointestinal Drugs
- Men's Health: The Market for Current and Emerging
- Outsourcing in Drug Development: The Contract Rese
- HIV: A Strategic Analysis of Therapeutic and Testing Markets
- Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and
Corrective Vision
- Critical Care Pharmaceutical Markets: A Strategic Analysis
- Glucose Testing
- Medical Imaging Markets, Volume I: Radiography
- The Protein Therapeutics Market: The Science and Business of a Growing Sector
- Medical and Biological Sensors and Sensor Systems - Markets, Applications, and
Competitors Worldwide, 2nd Edition
- The Impact of the Phase III Pipeline - Future Projections and Market
Disruptions
- The Worldwide Market for In Vitro Diagnostic Tests
- The Global Market for Adjunctive Therapies in Cancer, 2nd Edition
- The World Market for Generic Drugs, 5th Edition
- The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare
Products
- Needle-Free Drug Injection Systems and Safety Syringes - The Market for
Alternatives to Traditional Needle-Based Delivery
- The U.S. Market for Private Label OTC Healthcare Products
- The Worldwide Market for Prescription Dermatological Drugs, 5th Edition
- Future of Biotechnology Instrumentation, The
- Long-Term Care Market, The
- Outsourcing in Drug Discovery, 2nd Edition
- Transgenic Animals and Plants in Pharmaceutical Research and Manufacturing
- U.S. Market for Over-the-Counter Anti-Infectives,
- Advanced Drug Delivery: Technologies, Applications, and Markets, 2nd Ed.
- Clinical Diagnostics in China: Market Sector Analyses and Participant
Directory
- Market for Generic Biologics: Issues, Trends, and Market Potential, 2nd
edition, The
- World Market for Respiratory Equipment, The
- Worldwide Market for Pediatric Drugs, 2nd Edition,
- U.S. Market for Clinical Information Systems: An Analysis of the Growing Use
of Information Technology for Hospital-Based Patient Care, The
- Worldwide Market for Cancer Diagnostics, The
- Glycosylated Protein Therapeutics: A Market Briefing
- Implant-Based Dental Reconstruction: The Worldwide Implant and Bone Graft
Market
- U.S. Market for Cardiovascular Devices, The
- World Market for Neurotherapeutic Drugs, The
- Wound Care Markets, 2nd Edition, Vol III: Surgical and Trauma Wounds
- Complex Regional Pain Syndrome (CRPS): A Market Briefing
- Market for Clinical Nutritional Products, The
- Wound Care Markets, 2nd Edition, Vol II: Burns
- U.S. Market for Over-the-Counter Cough, Cold, Allergy, and Sinus Medications.,
The
- Wound Care Markets, 2nd Edition, Vol I: Skin Ulcer
- Business Insights
- Innovations in Cardiovascular Disease Management Latest surgical procedures
drugs and medical devices
- The Future of Biosimilars Key opportunities and emerging therapies
- Autoimmune Market Outlook to 2012
- Patent Protection Strategies Maximising product Revenues
- The Global HIV/AIDS Market Outlook to 2012
- Drug Repositioning Strategies Innovative strategies to boost pipeline
productivity
- Innovative and Targeted Cancer Therapies Key technologies new applications and
leading players
- The Indian Pharmaceutical Market to 2011 Competitive dynamics and major
players
- The Global Anti-Infectives Market Outlook to 2011
- The Women’s Health Market Outlook to 2011
- Winning Product Launch Strategies Maximizing sales from new pharmaceutical
products
- Indication Expansion Opportunities for successful lifecycle management
- The Dermatology Market Outlook to 2011
- eHealth Solutions for Pharma Strategies for salesforces marketing patient
compliance and clinical trials
- Future Growth Opportunities in Generics The impact of consolidation on market
and competitive dynamics
- Innovation in Drug Delivery The future of nanotechnology and non-invasive
protein delivery
- Next-Generation Nutraceuticals Food and pharma convergence in disease
prevention and personalized nutrition
- Innovations in CNS Novel therapeutics and future R&D strategies
- The Cardiovascular Market Outlook to 2011
- Innovations in Cancer Novel therapeutics new diagnostics and future R&D
strategies
- The Future of Metabolomics: Building competitive advantage in drug discovery
- The CNS Market Outlook to 2011
- The Cancer Market Outlook to 2011
- The Specialty Pharma Market Outlook - Key players, new company growth models
and emerging opportunities
- Pharmaceutical Strategic Alliances - Maximizing returns from collaborative
development and commercialization
- Innovations in Diagnostics - Next generation molecular and point-of-care
diagnostics driving personalized healthcare
- Pharmaceutical Growth Opportunities in Brazil, Russia, India and China -
Healthcare reform, market dynamics and key players
- The Future of Monoclonal Antibody Therapeutics - Innovation in antibody
engineering, key growth strategies and forecasts to 2011
- The Outlook for RNA
- The Asthma, COPD & Allergic Rhinitis Market Outlook to 20011
- Pharmaceutical Licensing Strategies: Best practice in deal-making, valuations
and strategic management
- The Pain Market Outlook to 2011
- Commercial Opportunities from Biomarkers: Transforming drug discovery,
clinical development and molecular diagnostics
- The Diabetes Market Outlook to 2011
- Pharmaceutical Growth Opportunities in the EU Accession States: Healthcare
reform, market dynamics and key players
- Pharmaceutical Outsourcing Strategies - Market expansion, offshoring and
strategic management in the CRO and CMO marketplace
- Opportunities in Stem Cell Research and Commercialization - Technology
advances, regulatory impact and key players
- Winning Pharmaceutical Brand Management - Maximizing brand value through best
practice in brand development and product marketing
- Predictive ADME and Toxicology Strategies - Challe- Challenges and
opportunities for in vivo, in vitro and in silico predictive technologies
- The Top 10 Generics Companies: Strategic insight, growth opportunities and
competitive dynamics in the US and Europe,
- Lifecycle Management Strategies: Maximizing ROI through indication expansion,
reformulation and Rx-to-OTC switching
- The Outlook For RNAi: Accelerating drug discovery and the development of RNAi
therapeutics
- The Future Of Array Technologies: Impact on drug discovery and market growth
in DNA, protein and tissue arrays
- The Future of Systems Biology: Emerging technologies and their impact on drug
discovery, development and diagnostics
- Lead Optimization Strategies: Future developments, threats and opportunities
for big pharma, specialty pharma and biotech
- The Latin American Cardiovascular Market Outlook t0 2010
- The Gastrointestinal Market Outlook to 2010
- Pharmaceutical Branding Strategies
- The Asian Cardiovascular Market Outlook to 2010
- The Eastern European Cardiovascular Market Outlook to 2010
- The Eastern European Cancer Market Outlook to 2010
- The Asian Cancer Market Outlook to 2010
- The Latin American Cancer Market Outlook to 2010
- The Emerging Drug Targets Outlookk - An analysis of novel molecular targets to
develop innovative new therapeutics
- The Cancer Market Outlook to 2010
- The Biotechnology Market Outlook: Growth opportunities and effective
strategies for licensing and collaborations
- Datamonitor
- Biosimilars Series Regulatory and development issues hurdles exist but are
surmountable
- Hospital Antibacterials A market beyond MRSA
- Business Blogging for Pharma
- Antidiabetics Safety becomes the critical factor for success
- Launch Strategies Analyzing Market Trends and Regulatory Impacts
- Heart failure Weak pipeline dominated by new indications and add-on diuretics
- R&D Strategies Incremental improvements and paradigm shifts in strategy are
both necessary to boost productivity
- Female Sexual Dysfunction Prescription Drug Pipeline Overview 2007
- Pediatric and Adolescent Vaccines
- Patient Empowerment empowered patients can change healthcare outcomes and
impact the pharmaceutical industry
- Antihypertensives New class opportunity offset by key patent expiries
- Antidyslipidemics The competitive cost-conscious antidyslipidemics market
presents challenges
- Asthma and COPD Combination products still have blockbuster potential
- HIV Reshaping Treatment Paradigms
- Upper GI Disorders Generics will limit pipeline profit
- Top 20 Cancer Therapy Brands Sales of targeted therapies overtake cytotoxics
in 2006
- Disease Management and Drug Adherence Strategies to support patients and
enhance treatment persistence
- Primary Brain Cancer
- Depression Atypical lifecycle management strategy rejuvenates depression
market
- Insomnia Strong brand identity critical to differentiation in an increasingly
crowded market
- Multiple Sclerosis Continued growth makes the MS market a highly attractive
investment
- Osteoporosis Risk management and reformulation offer best defense against
generic onslaught
- Monoclonal Antibodies Report Part I
- Spending on Telehealth Solutions in Europe 2007 to 2012 (Databook)
- Spending on Telehealth Solutions in North America through 2007 to 2012
(Databook)
- Irritable Bowel Syndrome Potentially profitable market is open for the taking
- Supportive Care in Oncology Significant growth opportunities exist in new
supportive care indications
- Hepatocellular Carcinoma Opportune indication for novel therapies
- Generic Series An Introduction to the Canadian Generics Market Key trends and
leading companies shaping the market
- Female Sexual Dysfunction Results from Datamonitor's 2005 physician survey
- Fibromyalgia Potentially lucrative market soon to become reality
- Disease Modification in Rheumatoid Arthritis Competition for the anti-TNF
failure patient population increases
- Insomnia Targeting the sleep maintenance market
- Benchmarking Patent Expiries Key Factors Affecting Brand Erosion at Patent
Expiry
- Antithrombotics Reaching the untreated prophylaxis market
- Dyslipidemia - Pipeline agents unlikely to rejuvenate the market
- Influenza Vaccines - Pandemic threat revitalizes the sector
- Hematological Malignancies Pursuit for the next blockbuster intensifies
- Multiple Sclerosis The oral revolution
- Osteoporosis Intermittent dosing drives market growth
- Pricing and Reimbursement Series Medicare Part D's progress so far
- Asthma Phenotypes A changing paradigm
- Depression Novel drugs to grow third-line market
- Nosocomial Infections The need for new gram-negative drugs
- ePrescribing Infrastructure and Impact on the Healthcare Markets in the US and
EU
- Atopic Dermatitis A high level of unmet need creates market opportunities
- Small Cell Lung Cancer and Malignant Mesothelioma Limited R&D activity
provides opportunity for early-phase pipeline drugs
- Esophageal Cancer Treatment paradigms need revolution not evolution
- The Pharmaceutical Industry Key trends and strategic issues shaping the
industry
- eHealth for the Pharmaceutical Industry What companies need to know about
trends in physicians and consumers use of the Internet
- HIV Change of guard
- Psoriasis Anti-TNF's lead another indication
- Osteoarthritis Market sees steady growth
- Atherosclerosis HDL ApoA-I Carotid MRI and 64-slice CT offer opportunities for
future treatment
- Multiple Sclerosis Disease-modifying efficacy and side effects guide treatment
choice
- Erectile Dysfunction Identifying product differentiation and patient
segmentation strategies
- Melanoma Lucrative commercial opportunities persist
- Respiratory Syncytial Virus RSV A market yet to reach its full potential
- Taking CRM to the Next Level Web-assisted relationship and community-building
for the pharmaceutical industry
- The Pharmaceutical Company Outlook to 2011 Financial and Strategic Analysis of
the Sales Outlook for Big Pharma Mid Pharma Japan Pharma and Biotech
- Biosimilars Benchmarking the key players With increasing regulatory clarity
and high revenue potential interest in biosimilars increases
- Obesity Lack of Reimbursement Limits Market Potential
- Antibacterials Growth in resistance rates drives niche indications
- Therapeutic Cancer Vaccines A turbulent path from bench to bedside
- Alzheimer's Disease Prescribing trends indicate that neurologists are not
adhering to guidelines
- Chinese Pharmaceutical Market Overview Regulatory reform and the evolving
healthcare market provide opportunities in china
- Antithrombotics Pipeline products to dampen the impact of patent expiries and
cost containment initiatives
- Migraine Innovation essential as weak late-stage pipeline fails to hold off
the impact of triptan patent expiries
- Pricing and Reimbursement in Oncology Do payers believe oncology drugs offer
good value
- Gynecological Cancers Niche opportunities in advanced disease
- Biosimilars Regulatory Issues Europe continues to make strides while the US
lags behind
- Drug Delivery Global Industry Guide
- Biotechnology Global Industry Guide
- Next-Generation Nutraceuticals Food and pharma convergence in disease
prevention and personalized nutrition
- Generics Global Industry Guide
- Optimizing Sales Force Effectiveness From quantity to quality
- Inflammatory Bowel Disease Competition Increases for the Biologics
- Respiratory Tract Infections in the USA The demise of narrow-spectrum
antibiotics
- Emerging eHealth Technologies Key trends impacting the physician-patient
relationship
- Breakthrough Pain Fast-acting players will capture majority market share
- Osteoarthritis The Wait for a DMOAD Continues
- Pricing and Reimbursement in Japan Costly healthcare system inefficiencies
increase the focus on healthcare cost containment
- Hormonal Contraceptives New directions in a competitive market
- Regulator Perceptions in Cancer Evolving opinions about the oncology drug
approval process
- Non-Small Cell Lung Cancer The need to differentiate in an increasingly
crowded and fragmented market
- Innovation in Drug Delivery The future of nanotechnology and non-invasive
protein delivery
- Asthma COPD Targeted therapies on the horizon
- Epilepsy Pipeline drugs struggle to outshine their marketed predecessors
- Colorectal Cancer Shaping the future dynamics of colorectal cancer management
- Molecular Targeted Cancer Therapies More drugs on the market more targets in
the pipeline
- Stakeholder Insight Atrial Fibrillation Limited efficacy and poor safety lead
to bleak outlook
- Stakeholder Insight Supportive Care in Cancer Treatment Some first-generation
products proving difficult to dislodge
- Hip and Knee Replacement Market-Overview of the US and European markets -
growth in a mature market
|
